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CD8+ T cells and NK cells are two effector cells of the mammalian immune system that 
rely on activating and inhibitory immunoreceptors to determine the outcome of an interaction 
with a target cell.  An infected or transformed target cell can upregulate a variety of ligands that 
bind to activating receptors.  Activating signals within an effector cell can then elicit responses 
that kill the target directly by lysing it or indirectly by secreting cytokines and chemokines that 
attract and activate other immune cells.  In contrast, a healthy target cell can maintain expression 
of ligands for inhibitory receptors that restrain effector cell functions.  NKG2A and KLRG1 are 
two examples of inhibitory immunoreceptors that are predominantly expressed on CD8+ T cells 
and NK cells.  Both molecules are C-type lectin-like proteins that are encoded within the NK 
gene complex (NKC) in the mouse and human genomes.  NKG2A forms a heterodimer with 
CD94 at the cell surface, while KLRG1 is expressed as a homodimer.  Both surface molecules 
transmit inhibitory signals through two cytosolic immunoreceptor tyrosine-based inhibitory 
motifs (ITIM). 
	  	   vii	  
A variety of specific functions have been attributed to both NKG2A and KLRG1, 
although in vivo verification is mostly lacking.  To this end, we have analyzed mice deficient in 
one or both molecules to unequivocally determine their functions in the context of the 
mammalian immune system.  We have further chosen to analyze their activity in the context of 
viral infection, as this is a physiologically important mode of activation of both CD8+ T cells and 
NK cells.  Specifically, we have studied the functions of NKG2A and KLRG1 in response to 
ectromelia virus (ECTV), an orthopoxvirus that is the mouse model of smallpox infection in 
humans.  We found that NKG2A in particular is necessary to control the systemic spread of 
ECTV.  Mice lacking NKG2A lack an effective CD8+ T cell response and are susceptible to 
infection.  Surprisingly, this is a T cell-intrinsic defect and may be attributable to a role for 
NKG2A in preventing antigen-induced apoptosis of activated CD8+ T cells.  Mice lacking both 
inhibitory receptors do not survive infection with ECTV, indicating that NKG2A and KLRG1 act 
in synergy to control this virus.  We further analyzed the functions of KLRG1 by assessing its 
role in controlling a transient viral infection in the lungs, where KLRG1 appears to regulate the 
effector CD8+ T cell response to intranasal HSV-1 infection.  Overall, these results illustrate 
novel in vivo roles for NKG2A and KLRG1 in the anti-viral response. 
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CHAPTER ONE:  Introduction 
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CD8+ T cell and Natural killer (NK) cell biology. CD8 T cells are a population of 
thymus-derived adaptive lymphocytes.  By the time they exit the thymus as mature, naïve 
T cells, they are capable of developing into cytotoxic T lymphocytes (CTLs).  They are 
important sentinels of the adaptive immune system, capable of recognizing cells that have 
become transformed or infected by any number of intracellular pathogens (Harty et al 
2005).  They are primarily activated through the binding of their T cell receptor (TCR) 
and the co-receptor CD8 to peptide-bound class I MHC complexes.  Upon activation, 
CTLs can directly kill a target cell in a perforin- and granzyme-dependent fashion.  They 
can also release cytokines and chemokines, notably IFNγ, to recruit other immune cell 
types, thereby indirectly inhibiting the propagation of an infection or tumor.  In the 
context of this study, we have been interested in analyzing the fine-tuning of this 
activation through interactions of other immunoreceptors expressed on the surface of 
CTLs, specifically NKG2A and KLRG1, which are introduced below. 
NK cells are a population of bone marrow-derived innate lymphocytes.  
Discovered in 1975, they have been shown to be indispensable for tumor 
immunosurveillance and the control of viral infections (Biron et al 1989, Dokun et al 
2001).  They have the ability to directly kill target cells in a perforin- and granzyme-
dependent manner.  They can also secrete an array of cytokines and chemokines to prime 
the innate and adaptive immune responses.  NK cells are distinct from the other major 
lymphocyte populations, T cells and B cells, in that their recognition receptors are 
germline-encoded and do not undergo somatic recombination. Therefore, NK cells are 
considered to be part of the innate immune system.  However, it has recently been shown 
that NK cells demonstrate properties that are considered to be unique to adaptive 
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immunity.  Hapten-mediated contact hypersensitivity, cytokine stimulation, and viral 
infections all appear to induce clonal expansion and more efficient secondary responses 
by NK cells (O’Leary et al 2006).  These behaviors resemble immunological memory, a 
hallmark property of adaptive immunity that was previously known to exist only in T and 
B cells.  Also, in a process that partially resembles the selection of thymocytes, NK cells 
can fully mature only after encountering self peptide-MHC (pMHC) complexes.  Upon 
exhibiting tolerance towards cells expressing pMHC complexes, NK cells are licensed to 
patrol the periphery for signs of cellular stress or viral infection.  Therefore, NK cells can 
be considered a transitional cell-type, one that exhibits some adaptive properties, but is 
able to innately respond to signs of stress without prior experience. 
NK cells develop from hematopoietic stem cells (HSC) in the bone marrow (Kim 
et al 2002).  Their development progresses through the common lymphoid progenitor 
(CLP), which can differentiate into T, B, NK, or NKT cells.  The more immediate 
precursor cell populations are the T and NK progenitor (T/NKP) and the NK progenitor 
(NKP) cells (Yokoyama et al 2004).  All of these populations develop in the bone 
marrow and their progression upon both direct and indirect interactions with bone 
marrow stromal cells.  Stem cell factor, FLT3 ligand, IL-7, and IL-15 are all required to 
develop phenotypically mature NK cells.  Expression of some cell surface receptors, such 
as the Ly49 family in mice, also requires cell-to-cell contact with stromal cells and their 
class-I MHC (Roth et al 2000).  NKPs already express CD122, the IL-2/IL-15 receptor β-
chain, making them responsive to stroma-derived IL-15.  During the ensuing stages in 
their development, the immature NK cells acquire cell surface receptors.  Among the 
earliest receptors to be expressed are members of the NKG2 complex, including NKG2D 
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homodimers and CD94/NKG2 heterodimers, as well as NK1.1 (Lian et al 2002).  In the 
mouse, Ly49 receptors are expressed following this acquisition.  Following the 
acquisition of the surface repertoires, NK cells undergo a round of expansion.  This 
expansion is mediated by the class I molecules on the bone marrow stroma and also 
begins the process of NK cell licensing (Yokoyama and Kim 2003), where successful 
interactions of the NK cell’s inhibitory receptors allow licensed NK cells to proliferate, 
gain functional maturity, and migrate to the periphery.  Unlicensed NK cells can also 
mature and migrate to the periphery, but they rely on external inflammatory stimuli, and 
not just direct adhesion to target cells, to fully activate. 
The development and functionality of mature NK cells are mediated by the 
interactions of a complex array of recognition receptors expressed on the NK cell surface 
(Vivier et al 2004).  These receptors can be broadly classified into two groups:  activating 
and inhibitory receptors.  Activating receptors associate with immunotyrosine activating 
motif (ITAM)-containing signaling molecules, including DAP-12, FcRγ, and CD3ζ.  
Inhibitory receptors contain tandem immunotyrosine inhibitory motifs (ITIMs) within 
their cytosolic domains, which recruit phosphatases to inhibit the activity of the signaling 
adaptors downstream of the ITAMs.  ITAM signaling generally proceeds by 
phosphorylating the tyrosine residues of Src family kinases, such as Lck and Fyn, 
recruiting them to the plasma membrane through interactions with their SH2 domains.  
Next, Syk family kinases, such as Syk and ZAP-70, are recruited and phosphorylated by 
the Src family members.  Following this step, an array of adaptor proteins, such as LAT 
at the membrane and SLP-76, PI3K, and Vav, are recruited to amplify and transmit the 
activation signals.  It is at this step that ITIM-recruited phosphatases, such as SHP-1 and 
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SHP-2, can be recruited to dampen the activation signals.  The balance of activating and 
inhibitory receptor engagement determines whether the kinases or phosphatases 
outcompete the other for engagement with target adaptors and scaffolding proteins.  If the 
activating signals are stronger, then the result is the activation of the mitogen-activated 
protein kinase (MAPK) pathway and an influx of calcium into the cells.  MAPK proteins 
activate MEK and ERK, which mediate cytotoxic responses by redistributing perforin 
and granzyme-containing granules (Jiang et al 2000).  Calcium influx leads to the 
activation of calmodulin and other signaling adaptors, which result in the transcription of 
cytokines and chemokines.  Another signaling adaptor, DAP-10, which associates with 
NKG2D, mediates a somewhat different activation pathway in NK cells (Diefenbach et al 
2002).  DAP-10 primarily signals through PI3K and can mediate a strong cytotoxic 
response, but has a less prominent role in the transcriptional control of cytokines. 
Most NK cell surface receptors recognize MHC class I and class I-like molecules 
on the surface of target cells (Lanier 2005).  In fact, when NK cell activity was first being 
described by Karre and colleagues, it was noted that the lack of H-2 expression on 
lymphoma targets controlled the cytotoxicy of NK cells.  This phenomenon was termed 
“missing self” and was contrasted with the activity of T cells, which are activated in the 
presence of non-self pMHC complexes (Karre et al 1986, Ljunggren et al 1990).  NK 
cells were thus considered an older lineage of lymphocytes that broadly recognized the 
subversion of pMHC expression on the surface of tumor cells.  The “Missing-self 
Hypothesis” has continued to be a pillar of NK cell biology, though the elucidation of its 
underlying mechanisms has led to a nuanced rethinking of missing-self.  In 1992, 
Yokoyama and colleagues demonstrated missing-self at the molecular level by showing 
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that NK cells expressing the inhibitory receptor Ly49A were unable to lyse target cells 
expressing the Ly49A ligand, H-2Dd (Karlhofer et al 1992).  Since this observation, it has 
become increasingly clear that the balance of activating and inhibitory signals within an 
NK cell determines the outcome of its interaction with a target.  If activation signals 
dominate, the NK cell remains adherent to the target, secreting cytokines and 
chemokines, and ultimately killing the target.  If inhibitory signals dominate or if there is 
no signal, the NK cell will be tolerant of the target, detaching and moving on to survey 
other cells. 
 
T cells and NK cells share many surface immunoreceptors.  The genes encoding many 
immunoreceptors expressed on activated CD8 T cells and NK cells are encoded in 
several locations on the mouse and human genomes.  The two main loci are the 
Leukocyte Receptor Complex (LRC), found on human chromosome 19 and mouse 
chromosome 7, and the NK Complex (NKC), on human chromosome 12 and mouse 
chromosome 6.  The LRC and the adjacent extended LRC encode the Siglec and CD66 
families, as well as the adaptor proteins DAP-10 and DAP-12.  It also contains the human 
KIR, ILT, and LAIR gene families, found only in humans, encode rapidly evolving sets 
of immunoglobulin superfamily proteins that are essential for human NK cell function.  
The NKC contains the Ly49 gene family, which encodes a set of C-type lectin proteins 
that seem to have functions analogous to the KIR proteins found in humans (Yokoyama 
and Plougastel 2003).  The NKC contains many other NK cell surface proteins, including 
CD69, KLRG1, and members of the CLEC and Dectin families.  It also houses the genes 
of the NKG2 complex, which is composed of CD94, NKG2A, NKG2C, and NKG2D, 
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and NKG2E, as well as NKG2F in humans (Figure 1).  This small group of lectin-like 
receptors has both activating and inhibitory functions.  NKG2A, C, and E all are able to 
form heterodimers with CD94 (Vance et al 1998, Vance et al 1999) and are expressed on 
approximately half of all NK cells.  NKG2/CD94 heterodimers are also expressed on 
NKT cells, γδ T cells, and activated CD8+ αβ T cells.  NKG2C and E are activating 
receptors that associate with DAP-12.  NKG2A contains two ITIMs in its cytoplasmic 
domain.  All three of these heterodimers bind to the non-classical MHC-Ib molecules 
HLA-E (in humans) and Qa-1b (in mice) (Aldrich et al 1988, Aldrich et al 1994, Kraft 
2000, Petrie et al 2008).  HLA-E/Qa-1b present nonamers of class I leader sequences in 
their peptide-binding groove and could provide a mechanism of immunoregulation by 
allowing NK cells and T cells to sample self-pMHC complexes on potential target cells 
(Hu et al 2004, Kim 2010, Lu et al 2006, Lu et al 2007).  It is also possible that 
CD94/NKG2 heterodimers are important in controlling viral infections, as shown with 
polyoma virus (Moser et al 2002), but they do not appear necessary for the development 
of NK cells (Vance et al 2002).  CD94 can form homodimers, as well, although the 
functionality of this association is unclear (Gunturi et al 2003, Orr et al 2010).  CD94 
contains no intracellular signaling motifs and it does not bind to HLA-E or Qa-1b. 
NKG2D is the only distantly related to the other genes of the NKG2 complex and it does 
not associate with CD94.  Instead, it is an activating receptor that forms homodimers and 
associates with the adaptor protein DAP-10.  NKG2D binds to molecules with structural 
similarities to MHC class I.  In humans, the ligands are MICA and MICB, as well as 
ULBP1, ULBP2, ULBP4, and ULBP4.  In mice, the ligands are members of the RAE-1 
family, as well as H60 and MULT1. 
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KLRG1, specifically, is another C-type lectin-like protein expressed on the 
surface of mature NK cells and activated CD8 T cells.  It is encoded at the centromeric 
end of the NKC, opposite of the NKG2 locus, in both mice and humans.  It is expressed 
as a homodimer and transmits inhibitory signals through two ITIM motifs (Figure 1).  
Each component of the homodimer contains one ITIM in its cytosolic region.  KLRG1 
binds to its ligand E-cadherin, which is expressed widely at epithelial and endothelial 
surfaces, although the biological function of this interaction has yet to be conclusively 
determined.  KLRG1 is commonly used as a marker of effector CD8 T cells and effector 
memory CD8 T cells (Sarkar et al 2008).  However, the functional significance of its 
expression on either T cell development or function has not been determined 
(Grundemann et al 2010).  Two hypotheses for why the function of KLRG1 has not yet 
been determined are that either its functions are 1) always redundant with another of the 
many inhibitory receptors co-expressed on the cell surface or that 2) highly specialized 
and specific.  To these ends, we will present evidence in Chapter Four that both of these 
hypotheses may be correct. 
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Figure 1 
 
 
 
Figure 1:  NKG2 molecules and KLRG1 in the mouse.  The NKG2 locus contains a 
family of C-type lectin-like proteins that are conserved in both mice and humans (A).  
NKG2A, C, and E are expressed in mice and form heterodimers with CD94.  NKG2A-
CD94 molecules are the lone inhibitory heterodimer expressed at the cell surface, 
signaling directly through 2 ITIM motifs found in the cytosolic portion of NKG2A.  
NKG2C and E both form activating heterodimers and signal through electrostatic 
interactions with a 3rd protein, ITAM-containing molecule, DAP-12.  The ligand for these 
heterodimers is Qa-1 in the mouse and HLA-E in humans, both nonclassical class 1b 
MHC molecules that present MHC signals peptides.  KLRG1 is another inhibitory lectin-
like protein that forms homodimers on the surface of NK cells and activated CD8 T cells 
(B).  It binds to E-cadherin and transmits inhibitory signals through its 2 ITIM motifs. 
A B
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T cell-NK cell interactions during viral infection.  Cytotoxic lymphocytes (CTLs) have 
essential functions in the clearance of viral infections, killing virally-infected cells and 
secreting interferon-γ (IFNγ) (Biron et al 2010).  In some cases, inhibition of NK cells 
prevents NK cell-mediated lysis of other cells participating in the adaptive immune 
response, such as dendritic cells, CD8 T cells (Waggoner et al 2010) or CD4 T cells (Lu 
et al 2007, Waggoner et al 2012).  This outcome may accelerate the clearance of virally 
infected cells, but may also result in excessive adaptive responses that cause tissue 
damage and immunopathology (Waggoner et al 2012). When viruses encode ligands that 
engage host inhibitory receptors, immunosurveillance is impaired and infection is 
sustained (Lanier et al 2008).  Several recent reports have highlighted the interplay 
between NK cells and T cells during viral infection (Waggoner et al 2010, Soderquest et 
al 2011).  NK cells are able to indirectly or directly regulate the CD8 response during 
infection in order to prevent immunopathology (Lee et al 2009, Waggoner et al 2011).  
CD8 Activated T cells are protected from direct NK cell killing through an interferon-
dependent mechanism (Crouse et al 2014).  T cells lacking IFNAR are highly susceptible 
to NK cell killing and cannot upregulate ligands for several inhibitory NK cell surface 
receptors, including Qa-1 (Xu et al 2014).  Qa-1 also appears to play a role in keeping 
autoimmunity-inducing CD4 T cell safe from NK cell killing (Lu et al 2007).  However, 
the precise roles of NKG2 molecules, whether on the surface of NK cells or T cells, 
during NK cell-mediated regulation of the antiviral T cell response is presently unknown.  
Another report suggests that, in fact, CD94-NKG2 heterdimers may be protective of both 
the NK cell and T cell responses during infection via cell-intrinsic mechanisms (Gunturi 
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et al 2003).  Thus, we have hypothesized that investigating the in vivo functions of the 
NKG2 complex may allow us to finely examine the role of a specific receptor-ligand pair 
and how it affects the interplay between T cells and NK cells during viral infections. 
Previous investigations of the function of NKG2A/CD94 in viral infections have 
yielded contrasting results.  One studies showed that NKG2A/CD94 inhibits CD8 T cell 
cytotoxic response against a polyoma virus infection (Moser et al 2002). Similarly, 
CD94/NKG2A inhibited NK-cell mediated killing of human cells infected with human 
cytomegalovirus (HCMV), since infected cells upregulated expression of HLA-E loaded 
with a gpUL40 peptide (Tomasec et al 2000, Wang et al 2002). In contrast, studies using 
lymphocytic choriomeningitis virus (LCMV) and listeria monocytogenes (LM) infections 
showed that CD94/NKG2A does not inhibit CD8 T cell effector functions (Miller et al 
2002, McMahon et al 2002).  
  
Ectromelia virus (ECTV).  Chapter Two focuses on studies that have elucidated a novel 
function of NKG2A in the CD8 response to ECTV, the causative agent of mousepox.  
ECTV is a large dsDNA virus, with a genome of approximately 210 kilobases (kb).  It is 
a member of the orthopoxvirus genus and is closely related to several other poxviruses, 
including variola (the causative agent of smallpox in humans), vaccinia, cowpox, and 
monkeypox (Esteban and Buller 2005).  It is used as a mouse model of smallpox and is 
also used to assess the requirements for immune control of other poxvirus infections, 
especially those like monkeypox virus, which can infect humans.  More recently, it was 
reported that CD94-/- mice are highly susceptible to ectromelia virus (ECTV) infection 
(Fang et al 2011). However, susceptibility to infection was not attributed to a defect of 
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CD94/Nkg2a, but to a defect of the activating CD94/Nkg2e/DAP12 complex, which 
triggered lysis of ECTV-infected cells, possibly through recognition of a viral peptide in 
the context of Qa1.  Given that NKG2A represents a large majority of CD94-NKG2 
heterodimers, we hypothesized that NKG2A may also have a role in this infection model. 
 
Other viral models of infection.  Another major aim of this work has been to assess the 
broader function of NKG2A and KLRG1.  Much of this work is presented in Chapters 
Three and Four, where we utilize several other models of mouse viral infection to 
elucidate further functions of inhibitory immunoreceptors in response to virus.  MCMV is 
a dsDNA virus (230 kb genome) of the betaherpesvirus subfamily.  Many reports have 
shown that NK cells are required to control MCMV infections (Dorner et al 2004, French 
and Yokoyama 2003).  More specifically, the Ly49H activating receptor on the surface of 
NK cells directly engages the viral protein m157, which is expressed on the surface of 
infected cells, leading to NK activation and killing of MCMV-infected target cells (Bubic 
et al 2004, Cavanaugh et al 2007, Voigt et al 2003).  In Chapter Three, we discuss the 
results of infecting NKG2A-/- mice with both WT MCMV and Δm157-MCMV (in which 
the m157 has been rendered non-functional) and analyze the role of NKG2A-mediated 
inhibition in altering the mechanisms of MCMV control. 
 Herpes simplex virus type 1 (HSV-1) is a ubiquitous human alphaherpesvirus that 
normally infects mucosal surfaces and then establishes latency in sensory neurons.  HSV-
1 is known to require both a competent innate and adaptive immune response in order to 
control the initial active infection and then requires a continuing adaptive response to 
maintain latency.  Here, we have assessed HSV-1 infection in two very different 
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tropisms.  In Chapter Three, we assess how NKG2A may affect the disease course of 
herpes stromal keratitis (HSK), which utilizes a skin and eye abrasion route of infection 
and models severe ocular infection in humans.  In Chapter Four, we use HSV-1 as a 
model of transient viral infection of the lungs and assess the role of KLRG1 in in 
regulating the CD8 response within the lungs.   
 
CD96 is a receptor for Nectin-like molecules at mucosal surfaces.  Nectins and nectin-
like (Necl) proteins are a group of Ig-superfamily proteins that mediate cell-to-cell 
adhesion in a variety of tissues (Fuchs 2006, Takai et al 2003).  Nectins bind in 
homophilic and heterophilic fashion to a variety of ligands.  These ligands include 
receptors expressed on the surfaces of lymphocytes (Shibuya 1996, Fuchs 2004).  Three 
of these receptors are depicted in Figure 2.  DNAM-1, CD96 (also known as Tactile), and 
WUCAM have been shown to bind Necl-5, also known as CD155 or PVR.  These three 
immunoreceptors are expressed on the surface of NK and T cells.  DNAM-1 has been 
shown to aid in the recognition of tumor cells expressing CD155 (Gilfillan et al 2008, 
Iguchi-Manaka et al 2008).  CD96 and WUCAM may compete with DNAM-1 for PVR-
binding, thereby regulating the immune response (Fuchs et al 2004, Boles et al 2009, Yu 
et al 2009).  Another receptor, CRTAM, binds Necl-2 and may activate cytolytic 
responses in a manner distinct from the PVR receptors (Yeh et al 2008).  Taken together, 
these interactions represent a distinct repertoire of activating and inhibitory immune 
mechanisms. 
 Finally, the end of Chapter Four briefly covers an initial study of CD96-/- mice in 
the context of mucosal immunity, specifically in the response to the attaching and 
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effacing gut bacterium, Citrobacter rodentium.  C. rodentium colonizes the distal colon 
and acts as a mouse model of enteropathogenic E. coli (EPEC) and enterohemorraghic E. 
coli (EHEC) infection (Bry and Brenner 2004).  In resistant mice, there are three general 
phases of infection:  colonization, symptomatic disease, and clearance.  The course of 
infection takes approximately three weeks in the B6 strain.  In susceptible strains, 
infection can become systemic, with bacteremia infecting the spleen, liver, and blood.  
Clearance requires IL-22 and a T-dependent systemic antibody response (Bry and 
Brenner 2004, Zheng et al 2008).  As PVR has been shown to be expressed at many 
mucosal surfaces, we hypothesized that CD96 may play a role in the response to C. 
rodentium (Boles et al 2009). 
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Figure 2 
 
 
 
Figure 2:  Interactions between immunoreceptors and Nectin or Nectin-like 
molecules.  Schematic of nectin and nectin-like proteins that interact with NK and CD8 T 
cell surface receptors.  WUCAM, DNAM-1, and CD96 all bind to PVR.  DNAM-1 also 
binds to Nectin-2, while CD96 also binds Nectin-1.  In general, nectin and nectin-like 
molecules are widely expressed on a variety of cell surfaces and interactions with their 
receptors are somewhat promiscuous and low-affinity. 
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CHAPTER TWO 
 
 
The work presented in this chapter is the focus of a manuscript entitled: 
Rapaport AS, Gilfillan S, Schriewer J, Hembrador E, Crump R, Plougastel BF, Gao J, Le 
Friec G, Cella M, Yokoyama WM, Buller RM, Colonna M.  NKG2A intrinsically 
prevents antigen-induced apoptosis of specific CD8+ T cells in response to an acutely 
lethal viral infection.  (manuscript in preparation) 
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Materials and Methods 
 
Mice.  A targeting vector that would replace the first four exons of the NKG2A genomic 
locus was tranfected into the B6blu embryonic stem cell line.  One of the 209 clones 
integrated properly, as judged by southern blot screening, and was injected into C57Bl/6 
blastocysts.  Mice heterozygous for the NKG2A deletion were successfully bred from the 
chimeric mice.  Heterozygote crosses resulted in the breeding of NKG2A-/- mice, which 
were born at Mendelian ratios and developed normally.  To ensure the fidelity of the line, 
NKG2A-/- mice were then intercrossed with WT C57BL/6 animals to generate new 
heterozygous mice, which were then bred to produce a new, backcrossed NKG2A-/- line. 
WT C57BL/6 and B6.RAG-1-/- were bred and housed in specific pathogen-free 
conditions at accredited animal facilities at Washington University in St. Louis and St. 
Louis University.  B6.SJL-Ptprca Pepcb/BoyJ males (CD45.1+ C57BL/6 strain) were 
purchased from Jackson Laboratory.   
 
BAC capture and sequencing of the NKG2 locus.  Multiplexed Paired-End Sequencing 
libraries were made using one microgram of WT or KO mouse genomic DNA according 
to Illumina protocol.  500 to 800 micrograms of 450-bp Adaptor-Modified DNA 
Fragments were obtained after 14 cycles of PCR amplification.  Libraries indexed 
individually were pooled together in order to obtain one microgram of total DNA. BAC 
RP23-145F22 (186kb) spanning the Klre1 to Klri2 region was used to capture the 
Nkg2a/Nkg2c region.  One hundred nanograms of biotinylated BAC DNA were 
hybridized for 72 hours to the denatured pooled Illumina libraries for which repeat 
sequences were blocked using mouse cot-1 DNA (Bashiardes et al. 1005).  After 
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hybridization, biotinylated BAC fragments were captured using 100 microliters of 
streptavidin-coated magnetic beads (Invitrogen) and washed using SDS/SSC solutions 
(Bashiardes et al. 1005).  Recovered DNA was amplified 12 more cycles using Illumina 
flow cell specific primers (F5: AATGATACGGCGACCACCGA and R7: 
CAAGCAGAAGACGGCATACGA).  PCR products were purified using 
Agencourt AMPure XP beads and quantified with a Qubit 2.0 Fluorometer (life 
Technology).  Fragments were sequenced on HiSeq 2500 instrument (Illumina, San 
Diego, CA) using 50 bp single-end sequencing option.  Reads in Fastq format were 
aligned to the BAC RP23-145F22 sequence using Bowtie-0.12.7 with the following 
options –t –v 2 –a –best –m 1 –q.  Alignments were visualized using Tablet (Milne et al., 
2013). 
 
Viruses and viral infections.  Plaque-purified ECTV (Moscow strain) was propagated in 
L929 cells and purified as previously described (Chen et al, 1992).  EV/NP-S-GFP 
(herein called ECTV-ova), which contains a FluNP-SIINFEKL-GFP cassette in the 
disrupted V region (CrmC) of ECTV-Moscow, was generated and described previously 
(Parker et al, 2007).  All ECTV and EV/NP-S-GFP infections were done via footpad 
(f.p.) at the indicated doses.  5x106 PFU Indiana strain VSV-ova was injected 
intravenously (i.v.). 
 
Cell culture.  BS-C-1, L929, and Vero cells were maintained in DMEM supplemented 
with 10% bovine calf serum, L-glutamine, non-essential amino acids, HEPES buffer, and 
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antibiotics.  YAC-1 cells and all primary cell preparations were maintained in RPMI-
1640 supplemented as above. 
 
Measurement of ECTV genome load in the blood.  ECTV viremia was assessed by 
quantitative real-time PCR of ECTV genomes as described previously (Esteban et al, 
2012).  Briefly, mice were bled 6 to 7 days post-infection by heart-stick or by 
submandibular bleed and 100ul of whole blood was collected into EDTA-coated 
collection tubes.  1.5ul whole blood was then applied directly into PCR reactions 
containing PCR Enhancer Cocktails and OminKlen Taq polymerase (DNA Polymerase 
Technology) to allow for efficient amplifiction of DNA from crude samples by SYBR 
green fluorescence detection (Invitrogen).  Primers for the ECTV gene EV107 were used 
for amplification (forward primer 5’- GTA GAA CGA CGC CAG AAT AAG AAT A -
3’; reverse primer 5’- AGA AGA TAT CAG ACG ATC CAC AAT C -3’). 
 
Preparation and staining of fixed tissue sections.  Spleens, livers, lungs, and kidneys 
from ECTV-infected mice were assessed for histology 6 days p.i.  All tissues were 
harvested directly into 10% buffered formalin and stored for 24 hrs at 4°C.  Tissues were 
then rinsed and transferred to 70% ethanol for 24 to 48 hrs.  Tissues were then paraffin-
embedded, sectioned, and subjected to hematoxylin and eosin (H&E) staining according 
to manufacturer’s instructions. 
 
Differential blood cell counts.  100ul blood from ECTV-infected mice was collected 6 
to 7 days p.i. by heart-stick directly into EDTA-containing collection tubes.  Complete 
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blood counts and white blood cell differentials were quantified by the Washington 
University Medical Center’s Division of Comparative Medicine. 
 
Flow cytometry.  Spleens and popliteal lymph nodes were digested in collagenase D for 
45 min at 37°C and passed through a 70um mesh filter to homogenize.  Cell preparations 
were Fc-blocked in a supernatant containing anti-CD16/CD32 for 15 minutes on ice, then 
surface-stained with antibodies or tetramers for 20 minutes on ice.  Cells were then 
washed and samples were run on either a BD FACS Calibur or BD FACS Canto II 
system.  For intracellular staining of IFNγ and CD107a, surface-stained cells were fixed 
in 2% PFA, then permeabilized and stained according to manufacturer’s instructions (BD 
Biosciences). Anti-CD3-FITC, anti-CD8-PE, anti-NK1.1-PerCP.Cy5.5, anti-NKG2-
biotin were obtained from eBioscience.  Anti-IFNγ-Alexa647 and anti-CD107a-FITC 
were obtained from BD Biosciences.  Tetramers for the poxvirus immunodominant B8R 
epitope (TSYKFESV-H2-Kb) were produced by the NIH Tetramer Core Facility. 
 
T cell restimulation assay.  Splenocytes from ECTV-infected mice were incubated 
overnight at 37°C in complete RPMI with either irrelevant peptide (SIINFEKL) or the 
poxvirus immunodominant peptide B8R (TSYKFESV).  Supernatants were collected and 
IFNγ concentration was measured with the Mouse Inflammation CBA kit (BD 
Biosciences).  
 
CD8+ cell enrichment and adoptive transfer.  CD45.1.WT and CD45.2.NKG2A-/- mice 
were challenged with 1x103 to 5x103 PFU ECTV-ova.  CD8+ T cells from infected mice 
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were enriched from spleens by magnetic beads (MACS cell separation, Miltenyi Biotec).  
WT and NKG2A-/- cells were counted, assessed for specific (B8R-Kb+) tetramer staining 
by flow, and co-transferred in a 1:1 mix of specific CD8+ T cells into RAG-1-/- host mice.  
Approximately 5x104 total B8R+ cells (2.5x104 from each strain) were transferred into 
each host mouse.  The hosts were infected with 1x103 PFU WT-ECTV f.p. the next day.  
The frequency and number of donor populations were then analyzed from the RAG-1-/- 
host spleens 7 days later.  To assess any role for T cell-extrinsic mechanisms of specific 
T cell survival, approximately 1x105 B8R+CD45.1+ WT cells were transferred alone into 
either CD45.2+ WT or CD45.2+ NKG2A-/- hosts.  Hosts were infected with WT-ECTV 
the next day and donor specific CD8+ T cell numbers were quantified from host spleens 7 
days p.i. 
 
NK cell activation assay.  Splenocytes from ECTV-infected mice were incubated for 6 
hours at 37°C with anti-CD107a antibody, in the presence or absence of 1x105 YAC-1 
target cells.  Brefeldin A and monensin were added for the final 5 hours of the incubation.  
Cells were then surface stained with anti-NK1.1 and anti-CD3 antibodies. fixed, 
permeabilized, and intracellularly stained with anti-IFNγ, before being analyzed by flow 
cytometry. 
 
T cell apoptosis assay.  Susceptibility of specific CD8+ T cells to apoptosis was assessed 
ex vivo, using a protocol modified from Guntari et al 2003.  Splenocytes from ECTV-
infected mice were put in culture in 96-well plates (2x106 cells/well) with complete RPMI 
supplemented with 13ng/ml recombinant human IL-2 (Peprotech).  1, 3, and 5 days later, 
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cells were stained with Annexin V and 7-AAD (PE Annexin V Apoptosis Detection Kit, 
BD Pharmingen) according to manufacturer’s instructions.  B8R-H2-Kb-APC tetramers 
and anti-CD8-FITC antibody were added to the staining cocktail to mark specific CD8+ T 
cells.  Cells were then assessed by flow on a BD FACS Calibur. 
 
Statistics.  A Student’s t test or multiple t tests were performed in Prism (GraphPad) in 
all cases.  Mean +/- SEM is represented on relevant graphs.  *p < 0.05; **p < 0.001; 
****p < 0.00001. 
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Results 
 
Generation of NKG2A-/- mice.  To generate NKG2A-/- mice, we designed a targeting 
vector to replace exons 1 through 4 of NKG2A with a floxed MC1-neor gene (Figure 
3A).  One targeted B6blu embryonic stem cell was injected into C57BL/6 blastocysts, and 
resulting chimeras were bred to C57BL/6 mice expressing a Cre transgene under the 
CMV promoter to delete the MC1-neor cassette and to generate NKG2A+/- heterozygous 
mice.  These mice were then bred and homozygous NKG2A-/- mice were obtained at 
Mendelian frequencies and developed normally out to one year. 
 
NKG2A does not play a role in T cell or NK cell development.  To begin to 
characterize the NKG2A-/- line and to assess whether or not NKG2A played a role in the 
development of T or NK cells, we first assessed the frequencies of lymphocyte 
populations in various peripheral tissues.  NK, NKT, and T cells from spleens, livers, and 
lungs were present in similar frequencies as control mice.  NK cells from NKG2A-/- mice 
exhibited no difference in maturation state, as judged by CD11b and CD27 expression 
(Figure 3B).  This is consistent with previous studies on DBA/2J mice, which are 
naturally deficient for CD94, yet exhibit no developmental defects (Vance et al 2002). 
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Figure 3 
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Figure 3:  Generating and characterizing NKG2A-/- mice.  Schematic representation 
of NKG2A-knockout targeting (A).  A targeting vector that would replace the first four 
exons of the NKG2A genomic locus was tranfected into the B6blu embryonic stem cell 
line.  One of the 209 clones integrated properly, as judged by southern blot screening, and 
was injected into C57BL/6 blastocysts.  Mice heterozygous for the NKG2A deletion were 
successfully bred from the chimeric mice. Heterozygote crosses resulted in the breeding 
of NKG2A-/- mice, which were born at Mendelian ratios and developed normally.  T cell 
and NK cell frequencies were assessed in spleens, mesenteric lymph nodes, and lungs (B, 
top row).  Peripheral NK cell populations were assessed for maturation markers CD11b 
and CD27 in the same tissues (B, bottom row). 
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Mouse NK cells lack surface expression of NKG2C and NKG2E.  To check that 
NKG2A expression was completely ablated in NKG2A-/- mice, we assessed the surfaced 
expression of NKG2A/C/E by flow cytometry using an antibody that recognizes all three 
mouse NKG2 family members.  Only a small population of naïve WT CD8+ T cells were 
positive for NKG2 expression.  CD8+ T cells from NKG2A-/- spleens also expressed little 
to no NKG2 surface molecules under homeostatic conditions.  After infection with 
ECTV, approximately one-quarter of WT CD8+ T cells were NKG2+, whereas only 0.5% 
of NKG2A-/- CD8+ T cells were NKG2+ (Figure 4A).  This data is in agreement with 
previous studies showing that NKG2 proteins are only expressed on CD8+ T cells upon 
activation and NKG2A comprises the large majority of the NKG2 molecules found in 
mouse NK cells (Vance et al 1999).   CD94 expression appears to be largely unchanged 
in NKG2A-/- CD8+ T cells (Figure 4C), though the lack of NKG2 expression in the 
knockout cells appears to result in a larger population of CD94 homodimer-expressing 
cells (Figure 4A, top right versus bottom right). 
We next assessed NKG2A/C/E expression on NK cells.  Approximately 40% of 
WT splenic NK cells exhibited NKG2 expression before and after infection.  
Surprisingly, however, NK cells from NKG2A-/- spleens exhibited a complete lack NKG2 
surface expression under any condition (Figure 4B), indicating that NKG2A is the only 
NKG2 family member expressed on the surface of mouse NK cells.  This result was 
confirmed by staining with an anti-CD94 antibody.  As shown in Figure 4D, CD94hi NK 
cells, which corresponds to cells expressing NKG2-CD94 heterodimers, is completely 
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absent in NKG2A-/- NK cells.  However, the CD94lo population, which corresponds to 
CD94 homodimer-expressing NK cells, is maintained. 
Furthermore, NKG2C/E transcripts are present at similar levels in spleens of both 
WT and NKG2A-/- mice, indicating that the deletion and point mutations did not disrupt 
any transcriptional regulation of the NKG2 locus (Figure 4E). 
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Figure 4 
 
Figure 4:  NK cells do not express NKG2C or NKG2E on the cell surface.  Spleens 
were analyzed by FACS for surface expression of NKG2A/C/E and CD94 under naïve 
conditions or 7 days after infection with 1000 PFU ECTV-Moscow f.p. WT cells are 
shown in the top row and NKG2A-/- cells in the bottom row.  CD8+ T cells (A) and NK 
cells (B) are depicted. CD94 expression was measured on the surface of splenic CD8+ T 
cells (C) and NK cells (D).  Both histograms depict naïve WT cells (black dashed line), 
naïve NKG2A-/- cells (red dashed line), ECTV-stimulated WT cells (black solid line), and 
ECTV-stimulated NKG2A-/- cells (red solid line). 
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NKG2A is important for the control of ECTV infection.  Previous studies have 
indicated that an intact, CD94-dependent cellular immune response is required to resist 
infection to ECTV.  We therefore hypothesized that NKG2A, which has been shown to 
be the primary NKG2 component of CD94-NKG2 heterodimers on the surface of mouse 
T and NK cells, may play an important role in controlling this infection.  We therefore 
challenged NKG2A-/- mice with a standard 1000 PFU of ECTV (Moscow strain) in the 
footpad and observed a strong susceptibility of NKG2A-/- male mice, as shown by 
increased morbidity and mortality (Figures 5A and 5B).  NKG2A-/- female mice are also 
susceptible to ECTV infection, as they exhibit increased viremia and splenic viral load 6 
days post-infection (Figures 5C and 5D).  It has been previously shown that among 
ECTV-susceptible strains, male mice are more susceptible than females (Brownstein et al 
1991).  Here, we also noted that males in general exhibit higher viremia and liver titers 
than their female counterparts (Figures 5C and 5D).  Thus, we conclude that the severe 
susceptibility of the NKG2A-/- males appears to be a combination of general male 
susceptibility to ECTV and a bona fide role for NKG2A in the anti-ECTV response. 
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Figure 5 
 
 
Figure 5:  NKG2A-/- mice are more susceptible to ECTV infection.  WT and NKG2A-
/- mice were infected in the footpad with 1000 PFU of ECTV f.p. and monitored for 
survival (A) and body weight (B) over time.  Viral load was assessed at 6 days post-
infection.  ECTV genome load in the blood was measured by quantitative RT-PCR (C).  
Spleen and liver viral loads were determined by plaque assay at 6 days p.i. (D).  In panels 
C and D, black bars indicate WT tissues and white bars indicate NKG2A-/- tissues.  All 
data is pooled from at least 2 independent experiments and was analyzed by multiple t 
tests. 
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The NKG2A-/- line contains an otherwise intact NKG2 locus and exhibits no other 
chromosomal mutations.  We next wanted to ensure that these initial results were only 
attributable to the elimination of NKG2A and not to a wider disruption of the NKG2 
locus brought on during targeting.  Multiple genes are in close proximity to the nkg2a 
gene within the NKG2 locus, so we assessed the entire locus of the NKG2A-/- line to 
ensure that its integrity was otherwise maintained.  To do this, we used BAC capture to 
enrich both WT and NKG2A-/- genomic DNA, then sequenced a 187kb region containing 
the NKG2 locus.  We then compared the sequence of each strain to a published C57BL/6 
reference sequence and annotated the mutations within the sequenced region.  There were 
no mutations in the WT line.  As shown in Table 1, the only mutations found within the 
NKG2A-/- line are an approximately 2.5kb deletion corresponding to the targeted deletion 
of NKG2A and 12 surrounding point mutations that were likely introduced during PCR 
amplification of the construct’s homology arms.  Also, as noted in Figure 4, CD94 
expression is unchanged in the NKG2A-/- line.  Combined, NKG2C, NKG2E, and CD94 
are the genes nearest to the targeted region and their unaltered expression appears to 
indicate that the targeted deletion of NKG2A was specific.  This allowed us to conclude 
that the NKG2A-/- strain contains an otherwise intact NKG2 locus. 
To rule out the possibility that the strain was generated with other chromosomal 
mutations, we intercrossed the initial NKG2A-/- line to C57BL/6 WT mice to create a 
new NKG2A-/- line.  The male mice from this new line were then infected with ECTV 
and the results corroborated previous results, specifically that NKG2A-/- male mice were 
highly susceptible to ECTV infection, as judged by increased mortality, body weight loss, 
and blood genome loads (Figure 6A-C).  We can therefore conclude that the NKG2A-/- 
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line is an intact C57BL/6 strain.  Together, this data demonstrates that NKG2A is indeed 
the dominant NKG2 molecule expressed on mouse CD8 T cells and the only NKG2 
molecule expressed on mouse NK cells. 
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Table 1 
 
Table 1: The	  NKG2	  locus	  of	  the	  NKG2A-­/-­	  strain	  remains	  essentially	  intact	  after	  
targeting.	  	  Mutations	  found	  within	  the	  NKG2A-­‐/-­‐	  locus	  are	  shown	  according	  to	  their	  position	  relative	  to	  the	  klrc1	  (nkg2a)	  transcriptional	  start	  site.	  	  Briefly,	  WT	  and	  NKG2A-­‐/-­‐	  genomic	  DNA	  was	  fragmented	  and	  enriched	  for	  NKG2	  locus-­‐specific	  fragments	  by	  BAC	  Capture.	  	  Enriched	  DNA	  was	  then	  cloned	  into	  a	  library,	  amplified,	  purified,	  and	  subjected	  to	  high-­‐throughput	  sequencing.	  	  Alignments	  were	  analyzed	  with	  Tablet	  software.	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Figure 6 
 
 
 
 
 
 
Figure 6:  Intercrossed NKG2A-/- males remain acutely susceptible to ECTV.  
NKG2A-/- mice were backcrossed to WT C57BL/6 mice and the F1 progeny were 
intercrossed to generate a new line of NKG2A-/- mice.  The F2 generation was then 
infected f.p. with 1000 PFU ECTV-Moscow and survival (A), body weight (B), and 
blood genome loads (C) were measured as done previously.  Data is representative of 
several independent experiments. 
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Spleens and blood of NKG2A-/- mice exhibit altered histopathology and cell counts.  
To assess why NKG2A-/- mice are susceptible to ECTV infection, assessed the 
histopathology of several peripheral organs known to be infected by ECTV (Buller 
review citation).  As shown by H&E staining, NKG2A-/- mice appear to be exhibit altered 
histopathology and are highly acellular compared to WT controls 7 days post-infection 
(Figures 7A and 7B).  In contrast, NKG2A-/- livers, lungs, and kidneys appear to remain 
largely intact after ECTV infection and comparable to WT tissues (Figures 7C-7H). 
We hypothesized that this pathology may be related to a dysfunctional CD8+ T 
cell response, given that this time-point corresponds to a robust effector CD8+ T cell 
response and that NKG2A is expressed on activated CD8+ T cells.  We therefore 
analyzed the frequency and number of specific CD8+ T cells in both WT and NKG2A-/- 
spleens by staining splenocytes with H2-Kb tetramers bound with the poxvirus 
immunodominant peptide B8R (sequence:  TSYKFESV).  We noted a slight reduction in 
specific cell frequency in NKG2A-/- mice and a significant reduction in the total number 
of specific CD8+ T cells per spleen (Figures 7I and 7J).   Both the frequency and total 
numbers differed in a gender-independent fashion. 
 Given the altered splenic pathology and increased viremia in NKG2A-/- mice, we 
also sought to assess the blood for any disruptions in cellularity.  At 7 days post-
infection, we noted significant increases in total WBC counts in NKG2A-/- whole blood, 
and specifically in the number of neutrophils and lymphocytes in the blood (Figure 7K).  
At the same time, there was also a corresponding reduction in the number of platelets per 
volume of blood.  Therefore, it appears that NKG2A-deficiency results specifically in 
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splenic and blood pathologies and that altered CD8+ T cell survival or function may be 
the cause of NKG2A-/- susceptibility to ECTV. 
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Figure 7 
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Figure 7:  Characterization of ECTV-infected spleens and blood in WT and 
NKG2A-/- mice.  Mice were infected in the footpad with 1000 PFU ECTV f.p. and 
tissues were analyzed by H&E staining 6 days post-infection.  Spleens (A, B), livers (C, 
D), kidneys (E, F), and lungs (G, H) were assessed.  WT tissues are in the top row (panels 
A, C, E, G) and NKG2A-/- tissues are in the bottom row (panels B, D, F, H).  Spleens 
were also analyzed for a specific CD8+ T cell response.  CD8+ T cells were gated on 
CD3+CD8+ lymphocytes and assessed for TCR specificity by B8R-H2-Kb tetramer 
staining.  The frequency (I) and total number (J) of B8R-specific CD8+ T cells were 
quantified from WT (black bars) and NKG2A-/- splenocytes (white bars).  Blood was 
collected from ECTV-infected animals 6 days p.i. and was assessed by CBC and WBC 
differentials.  Total white blood cells, segmented neutrophils, lymphocytes, and platelets 
are shown (K).  All data are pooled from at least 2 independent experiments and were 
analyzed by multiple t tests. 
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NKG2A is intrinsically important to CD8+ T cell proliferation during ECTV 
infection.  Given that NKG2A is known to be upregulated on activated CD8+ T cells, we 
first hypothesized that the suboptimal CD8 response in NKG2A-/- mice may be due to a 
cell-intrinsic defect.  To test this in vivo, we wanted to design an adoptive transfer 
experiment that would allow us to observe NKG2A-/- specific CD8+ T cells in 
competition with WT specific CD8+ T cells during ECTV infection.  However, since WT 
virus would cause NKG2A-/- to succumb to infection before we could isolate their 
specific T cells, we wanted to use a less virulent strain of ECTV to vaccinate donor mice.  
To this end, we utilized an ova-transgenic strain of ECTV (EV/NP-S-GFP), which does 
not kill NKG2A-/- male mice (Figure 8).  We thus used this virus to produce a pool of 
donor T cells, which were then applied to an adoptive transfer experiment (Figure 9A).  
To generate a pool of specific T cells, CD45.1 WT mice and CD45.2 NKG2A-/- mice 
were infected with ECTV-ova.  Approximately 1 week post-infection, splenic CD8+ T 
cells from each strain were enriched and assessed for TCR specifity by staining with 
B8R-H2-Kb tetramers (Figure 9B).  WT and NKG2A-/- cells were then mixed at a 1:1 
ratio of tetramer+ cells (Figure 9C).  This mixture was then injected i.v. into RAG-1-/- 
hosts, which were infected with WT-ECTV 1 day post-transfer.  As a control, some 
RAG-1-/- mice were given the T cell mixture, but not infected with virus.  One week post-
infection, uninfected RAG-1-/- spleens did not exhibit a significant population of specific 
T cells 8 days post-transfer.  Hosts that were infected with WT virus, however, showed a 
noticeable population of specific CD8+ T cells (Figure 9D).  In the infected hosts, WT 
specific donor cells were more frequent and significantly outnumbered NKG2A-/- donor 
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cells (Figures 9E and 9F).  This result establishes an in vivo, cell-intrinsic role for 
NKG2A on antigen-specific CD8+ T cells in response to ECTV. 
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Figure 8 
 
 
 
 
 
 
Figure 8:  ECTV-ova does not cause death in NKG2A-/- males.  WT and NKG2A-/- 
male mice were infected f.p. with the indicated dose of either wild type ECTV or ECTV-
ova and were monitored for mortality out to 7 weeks. 
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Figure 9 
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Figure	  9:	  	  The	  defective	  response	  to	  ECTV	  by	  NKG2A-­/-­	  CD8+	  T	  cells	  is	  cell-­
intrinsic.	  	  Schematic	  to	  test	  for	  a	  cell-­‐intrinsic	  mechanism	  of	  NKG2A	  function	  in	  ECTV-­‐specific	  CD8+	  T	  cells	  (A).	  	  WTCD45.1	  and	  NKG2A-­‐/-­‐	  mice	  were	  vaccinated	  with	  5000PFU	  ECTV-­‐ova	  f.p.	  and	  CD8+	  cells	  were	  enriched	  from	  spleens	  7	  days	  p.i.	  (B).	  	  Cells	  were	  mixed	  at	  a	  1:1	  ratio	  of	  B8R-­‐Kb+	  cells	  and	  then	  adoptively	  transferred	  into	  RAG-­‐1-­‐/-­‐	  hosts	  (C).	  	  RAG-­‐1-­‐/-­‐	  hosts	  were	  either	  left	  uninfected	  or	  were	  infected	  with	  ECTV-­‐WT	  for	  7	  days,	  then	  analyzed	  for	  B8R-­‐Kb-­‐specific	  CD8+	  T	  cells	  (D).	  Frequencies	  of	  WT	  and	  NKG2A-­‐/-­‐	  CD3+CD8+B8R-­‐Kb+	  cells	  from	  RAG-­‐1-­‐/-­‐	  spleens	  7	  days	  post-­‐infection	  with	  ECTV-­‐WT	  (E).	  	  Total	  CD3+CD8+B8R-­‐Kb+	  cell	  numbers	  from	  RAG-­‐1-­‐/-­‐	  spleens	  7	  days	  post-­‐infection	  with	  ECTV-­‐WT	  (F).	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Cell-extrinsic NKG2A-deficiency does not affect CD8+ T cell proliferation during 
ECTV infection.  Although NKG2A-/- CD8+ T cells are intrinsically less stable than their 
WT counterparts after ECTV infection, it remained to be seen if a T cell-extrinsic 
mechanism may also contribute to the dysfunctional CD8 response we observed in 
NKG2A-/- mice.  To test in vivo whether any other NKG2A-expressing cell affected the 
CD8 response, we designed another adoptive transfer experiment that would allow us to 
observe how donor WT specific CD8+ T cells survived in either a WT or NKG2A-/- host 
environment following ECTV infection (Figure 10A).  As shown in Figure 10B, CD45.1-
marked WT specific CD8+ T cells survived equally well in both WT and NKG2A-/- hosts, 
as judged by the number of B8R-H2-Kb+CD45.1+ donor cells present in host spleens 7 
days post-infection with WT-ECTV.  This indicates that NKG2A expression on any cell 
other than the B8R-specific CD8+ T cells appears to be unimportant for a functional 
specific T cell response.  
 
NKG2A-/- NK cells exhibit normal functionality during ECTV infection.  Mature 
peripheral NK cells constitutively express NKG2A on their surface and, given that they 
function relatively similarly activated CD8+ T cells, we hypothesized that NK cells may 
exhibit altered functionality following ECTV infection.  To assess whether NKG2A-/- NK 
cell function was broadly altered after ECTV infection, we quantified the viral burden in 
draining popliteal lymph nodes 3 days after f.p. infection with WT-ECTV (Figure 10C).  
Early resistance to ECTV is more dependent on NK cells and popliteal lymph nodes are 
the primary location for viral replication prior to systemic infection (Parker et al 2007).  
However, there was no difference in viral burden in popliteal lymph nodes at this time, 
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suggesting that NKG2A plays an insignificant role in early NK cell-control of ECTV 
infection.  We also assessed NK cell function in the spleen at 6 days post-infection, a 
time-point when NKG2A expression on CD8+ T cell control appears to be important for 
viral control.  WT and NKG2A-/- NK cells restimulated with target cells express 
equivalent levels of both IFNg and CD107a, indicating that NK cell function is largely 
maintained in the absence of NKG2A (Figure 10D).  Together, this data indicates that 
NKG2A expression on NK cells appears to have no effect on the control of ECTV 
infection.  This data also reinforces the T cell adoptive transfer studies presented in 
Figures 8 and 9, demonstrating an important role for NKG2A only on specific T cells. 
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Figure 10 
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Figure	  10:	  	  The	  defective	  response	  to	  ECTV	  by	  NKG2A-­/-­	  CD8+	  T	  cells	  is	  not	  cell-­
extrinsic.	  Schematic	  to	  test	  for	  a	  cell-­‐extrinsic	  mechanism	  of	  NKG2A	  function	  in	  ECTV-­‐specific	  CD8+	  T	  cells	  (A).	  	  WTCD45.1	  mice	  were	  vaccinated	  with	  5000PFU	  ECTV-­‐ova	  f.p.	  and	  CD8+	  cells	  were	  enriched	  from	  spleens	  7	  days	  later.	  	  Cells	  were	  then	  adoptively	  transferred	  into	  either	  WT	  or	  NKG2A-­‐/-­‐	  hosts.	  	  The	  next	  day,	  host	  mice	  were	  infected	  with	  1000	  PFU	  ECTV-­‐WT	  f.p.	  	  Seven	  days	  later,	  host	  spleens	  were	  isolated	  and	  donor	  T	  cell	  populations	  were	  analyzed	  by	  flow.	  	  Total	  number	  of	  specific	  donor	  cells	  (CD45.1+CD3+CD8+B8R-­‐Kb+	  cells)	  from	  WT	  and	  NKG2A-­‐/-­‐	  hosts	  7	  days	  after	  infection	  with	  ECTV-­‐WT	  (B).	  	  Viral	  load	  in	  popliteal	  lymph	  nodes	  was	  assessed	  by	  plaque	  assay	  3	  days	  p.i.	  with	  1000	  PFU	  ECTV-­‐WT	  f.p.	  (C).	  	  Expression	  of	  IFNγ	  and	  CD107a	  by	  splenic	  NK	  cells	  5.5	  days	  post-­‐infection	  with	  1000	  PFU	  ECTV-­‐WT	  f.p.	  	  Splenocytes	  were	  incubated	  in	  the	  presence	  of	  anti-­‐CD107a	  antibody	  with	  or	  without	  YAC-­‐1	  targets	  cells	  for	  6	  hours.	  	  Cells	  were	  then	  stained	  for	  intracellular	  IFNγ.	  	  Dot	  plots	  show	  CD107a	  and	  IFNγ	  expression	  on	  CD3-­‐NK1.1+	  NK	  cells	  (D).	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NKG2A-/- specific T cells are more susceptible to apoptosis ex vivo.  Since NKG2A 
appears to play a cell-intrinsic role in regulating the CD8 response to ECTV, we 
hypothesized that the specific response may be maintained by NKG2A’s inhibitory 
signaling and that in the absence of NKG2A, ECTV-specific CD8+ T cells may be more 
susceptible to overactivation and cell-death.  To test this hypothesis, we measured 
specific T cell viability versus apoptosis ex vivo.  Splenocytes from ECTV infected mice 
were cultured in the presence of low levels of IL-2 and viability and Annexin V binding 
were measured 1, 3, and 5 days after plating.  WT specific cell numbers increased ex 
vivo, whereas NKG2A-/- specific cell numbers decreased over the same time period 
(Figure 11A).  The inverse was true of Annexin V staining, where less than 5% of WT 
cells were Annexin V+ by day 3, but approximately 25% of the remaining NKG21A-/- 
specific CD8+ T cells were beginning to undergo apoptosis (Figure 11B).  Together, this 
data suggests that NKG2A prevents excessive apoptosis of specific T cells during an 
acutely severe viral infection, thereby maintaining the CD8 response long enough to 
ensure viral clearance. 
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Figure 11 
 
 
  
Figure 11:  NKG2A-/- ECTV-specific CD8+ T cells are more susceptible to apoptosis 
ex vivo.  WT and NKG2A-/- splenocytes were isolated 7 days after ECTV infection and 
cultured in complete RPMI containing 13ng/ml rhIL-2.  At 1, 3, and 5 days post-culture, 
numbers of CD8+B8R-H2Kb+ cells were quantified (A) and assessed for Annexin V 
staining (B).  Both panels show WT specific CD8+ cells (filled circles) and NKG2A-/- 
specific CD8+ cells (open circles).  Data is representative of 3 independent experiments.  
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CHAPTER THREE 
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Materials and Methods 
 
Viruses and Viral infections.  5x106 PFU Indiana strain VSV-ova was injected 
intravenously (i.v.).  LCMV clone 13 was administered i.v. at 2x106 PFU per mouse.  
Vaccinia virus (VV) containing a SIINFEKL-GFP cassette was a gift from Jonathon 
Yewdell (NIAID).  For VV infections, Mice were injected f.p. with 1x107 PFU virus.  
HSV-1 strain 17 was administered by corneal scarification (see below) at 2x106 
PFU/cornea.  Viruses were propagated on Vero cell monolayers.  Viral load was assessed 
from various tissues by standard plaque assays on Vero cell monolayers. 
 
HSV-1 Corneal Scarification.  Mice were anesthetized with a ketamine-xylazine 
cocktail and scarified using a 25G needle passed lightly across the entire area of the 
cornea in approximately 16 strokes.  Scarified mice were then inoculated with HSV-1 
strain 17 at the indicated dose in a volume of 5ul and the inoculum was spread over the 
entire surface of the cornea and immediate surrounding periocular skin (POS).  To assess 
viral load in a time-course following inoculation, eye swabs were taken at days 1, 3, 5, 
and 7.  Swabs were then used to inoculate sterile DMEM, which was then used for 
standard Vero cell plaque assays. 
 
HSV-1 Clinical Scoring.  A scoring system was developed to specifically quantify skin 
inflammation and lesion formation after corneal infection with HSV-1.  Scores ranged 
from 0 to 4 and were assessed via the following characteristics:  0 = no visible 
inflammation or lesion formation, 0.5 = minimal swelling of the surrounding skin, 1.0 = 
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inflammation and some hair loss on the POS, 1.5 = 1.0 characteristics plus pink skin, 2.0 
= lesion formation and discharge from POS, 2.5 = 2.0 characteristics plus excessive 
inflammation, 3.0 = red, raw lesions, 3.5 = 3.0 characteristics plus symptoms of 
neurological dysfunction, 4.0 = severe neurological decay and moribund mice. 
 
HSV-1 Reactivation Assay.  Reactivation assays were done as described previously 
(Gierasch et al 2006).  Briefly, trigeminal ganglia were isolated 4 weeks post-infection, 
bisected, and put in culture on Vero cell monolayer.  Supernatants were collected out to 7 
days and added to a fresh monolayer.  Evidence of reactivation was determined as plaque 
formation on the fresh Vero cell monolayer. 
 
MCMV Propagation and Infection.  Both MCMV-WT and MCMV-Δm157 were 
propagated for salivary gland stocks.  BALB/c females were injected i.p. with MCMV 
and 14 days later, salivary glands were isolated and homogenized with dounce 
homogenizers.  Homogenates were spun down and supernatants were aliquoted and kept 
frozen at -80°C.  In lieu of plaque assays, MCMV-WT stock concentration was estimated 
by infecting C57BL/6 female mice on a dose curve so that an LD50 could be determined.  
On the B6 background, the LD50 has been previously determined to be 2.5x105 
PFU/mouse.  For survival experiments, WT and NKG2A-/- mice were infected i.p. with 
4ul of MCMV-WT. 
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Cytokine Assays.  Serum samples were collected at various time-points and assessed for 
IFNα concentration by ELISA (PBL Interferon Source) and for IFNγ by flow cytometry 
using the Mouse Inflammation CBA kit (BD Biosciences). 
 
NK cell licensing assay.  Licensing of splenic NK cells was done as described previously 
(Kim et al 2005).  Here, 6-well plates were coated with 5ul purified anti-NK1.1 for 90 
minutes in PBS at 37°C.  1x107 splenocytes were then added and incubated for an 
additional 1 hr.  Brefeldin A was then added and cultures were incubated for a further 7 
hrs.  Cells were then surface stained with anti-CD3, anti-DX5, and anti-NKG2A/C/E.  
Cells were then fixed, permeabilized, and intracellularly stained with anti-IFNγ.  Cells 
were then assessed by flow on a FACS Canto II system. 
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Results 
 
NKG2A is dispensable for control of LCMV and VSV infection in vivo.  Our previous 
work had demonstrated an important role for NKG2A in the host response to ECTV.  
However, ECTV is somewhat unusual among mouse models of viral infection in that it is 
acutely lethal in many murine strains at low infectious doses, requiring robust innate and 
adaptive responses even during subcutaneous infections of as little as 1000 PFU of virus.  
We were therefore interested in determining whether NKG2A is broadly necessary for 
combating viral infections and, furthermore, how different viruses could affect the CD8 
response in the absence of NKG2A.  To do this, we chose to infect WT and NKG2A-/- 
mice with viruses that are acutely nonlethal (VSV-OVA) or chronically nonlethal virus 
(LCMV clone 13) in the C57BL/6 background, as well as with an orthopoxvirus that is 
highly homologous to ECTV (vaccinia virus).  VSV-OVA splenic viral load was 
unchanged in NKG2A-/- mice 8 hrs p.i. (Figure 12A).  At 7 days p.i., after replicating 
virus has been cleared on C57BL/6 background, the specific CD8 response in NKG2A-/- 
spleens was similar to WT controls, as judged by Kb-OVA tetramer staining (Figure 
12B).  15 days after infection with LCMV clone 13, viral loads in spleen, liver, kidney, 
and lung were all unchanged in NKG2A-/- mice (Figure 12C). 
	  	   55	  
Figure 12 
 
 
 
Figure 12:  NKG2A is dispensible for the immune response to VSV, LCMV, and 
vaccinia virus.  WT and NKG2A-/- mice were infected i.v. with 5x106 PFU VSV-ova.  
Splenic viral burden at 8 hrs p.i. was measured by plaque assay (A).  Ova-specific CD8 
responses were measured by Kb-ova tetramer staining of splenocytes 7 days p.i. (B).  For 
LCMV infections, mice were infected i.v. with 2x106 PFU LCMV clone 13 and viral load 
was measured in spleen, liver, kidney, and lung tissue at 15 days p.i. by plaque assay (C). 
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NKG2A is dispensible for the immune response to vaccinia virus.  Vaccinia virus 
(VV) is a member of the orthopoxvirus genus that is highly related to ECTV.  We 
hypothesized that, although NKG2A appears to be dispensible for many viral infections, 
it may be broadly necessary for the immune response to poxviruses.  Therefore, we 
wanted to infect NKG2A-/- mice with VV and broadly assess their response.  Following 
infection with VV, both WT and NKG2A-/- male mice lost little to no weight (Figure 
13A).  Furthermore, there appeared to be no defect in the NKG2A-/- specific CD8 T cell 
response to VV, as judged by tetramer staining (Figure 13B).  The overall frequency of 
tetramer+ cells and total CD8 T cells was virtually unchanged 9 days post-infection 
(Figure 13C), a time-point at which NKG2A-/- male mice would have largely succumbed 
to ECTV infection.  Given that VV shares a high sequence homology to ECTV, yet lacks 
most of its virulence in mouse hosts, this data indicates that NKG2A may be necessary 
only during acutely severe viral infections, or perhaps specifically during ECTV 
infection.  This would contrast with the idea that a Qa-1-specific peptide derived from 
orthopoxviruses is the root cause of NKG2A’s role during viral infection.  Instead, it may 
be that NKG2A dampens specific CD8 antigen-induced activation, so as to prevent 
excessive antigen-induced overactivation and apoptosis. 
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Figure 13 
(Experiments presented in this figure were done with the help of Marina Cella.) 
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Figure 13:  NKG2A is dispensible for the response to vaccinia virus.  Mice were 
infected f.p. with 1x107 VV-SIINFEKL-GFP and body weights were monitored for 9 
days (A).  Splenocytes were stained for CD8 T cell markers and assessed for specificity 
via Kb-ova tetramer staining 9 days p.i. (B).  Frequencies of tetramer+ cells and total CD8 
T cells were calculated 9 days p.i. from popliteal lymph nodes and spleens (C). 
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NKG2A plays a minor role in maintaining tissue integrity following corneal 
infection with HSV-1.  A previous study had indicated an important role for Qa-1 in the 
CD8 response to herpes stromal keratitis (HSK) (Hu et al 2004).  We hypothesized that as 
a major component of NKG2-CD94 heterodimers, NKG2A may be an important receptor 
for Qa-1 in this model.  To assess the role of NKG2A, we infected mice with HSV-1 
strain 17 via corneal scarification and monitored clinical progression of disease out to 2 
weeks post-infection.  Clinical scoring of the cornea and surrounding tissue indicated that 
WT mice displayed detectable but minimal inflammation and no lesion formation of the 
surrounding tissues following infection.  NKG2A-/- mice exhibited increased 
inflammation and some lesion formation on the periocular skin (Figure 14A).  This data 
indicated that NKG2A played a minor role in the inflammatory response to HSK, as there 
was a low but detectable difference in average clinical scores of WT versus NKG2A-/- 
mice (WT ~ 1.0 versus NKG2A-/- ~ 2.0, on a scale of 1 to 5).  This phenotype, however, 
did not correspond to any differences in the activity, latency, or virulence of HSV-1.  
Active viral replication on the cornea, within periocular skin, or within the trigeminal 
ganglia (TG) was unchanged in NKG2A-/- mice (Figures 14B and 14C).  Latent HSV-1 
genome loads in the TG were also unaffected (Figure 14D). Overall survival was 
unchanged in NKG2A-/- mice (Figure 14E), as was the frequency of viral reactivation in 
an explanted TG culture system (Figure 14F).  Overall, this data indicated that NKG2A 
appears to have a slight role in controlling or resolving inflammation in response to 
corneal infection with HSV-1, but it does not affect the activity or latency of the virus in 
any relevant tissue. 
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Figure 14 
(Some experiments presented here were done in collaboration with the Leib laboratory) 
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Figure 14:  NKG2A helps control local inflammation in response to HSV-1 corneal 
infection.  WT and NKG2A-/- mice were infected with 2x106 PFU HSV-1 strain 17 per 
eye following corneal scarification and inflammation was scored out to 2 weeks post-
infection (A).  Infected eyes were swabbed at the indicated time-points and viral load was 
assess by plaque assays (B).  Trigeminal ganglia and periocular skin were isolated 3 days 
p.i. and viral load was measured by standard plaque assays (C).  HSV-1 genomes were 
measured from the trigeminal ganglia by quantitative PCR (D).  Following infection, 
mice were monitored for survival out to 3 weeks post-infection (E).  Reactivation of 
HSV-1 was assessed by plaque assays of culture media exposed to explanted trigeminal 
ganglia (F). 
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NKG2A-/- mice are resistant to MCMV at a high infectious dose.  NK cells are well 
established as being necessary to mount a competent innate response to mouse 
cytomegalovirus (MCMV).  Although this response is highly dependent on the activating 
receptor Ly49H, which binds the MCMV-encoded protein m157, we hypothesized that 
NKG2A may have a function in fine-tuning the host response to MCMV.  To test this, we 
infected mice with two strains of MCMV, both the WT strain and an escape mutant that 
lacks m157 (MCMV-Δm157).  We first established an infectious dose of our wild type 
MCMV stock that was capable of inducing morbidity and mortality in C57BL/6 mice 
(Figure 15A).  We subsequently estimated the LD50 (which has been previously 
calculated to be 2.5x105 PFU/mouse when injected i.p.) of our inoculum to be 4ul of the 
inoculum diluted to 100ul in sterile PBS.  Using this dose, we then infected WT and 
NKG2A-/- mice with MCMV and assessed morbidity and mortality for 2 to 3 weeks post-
infection.  We found that NKG2A-/- mice were resistant to infection as judged by a 
reduction in mortality and body weight loss (Figures 15B and 15C).  We also noted that 
NK cell frequencies were increased in NKG2A-/- spleens at days 1 through 6 p.i. (Figure 
15D).   
 In a separate but related set of experiments, we analyzed the cytokine response of 
NKG2A-/- mice to MCMV-Δm157.  We noted that at 36 hrs p.i., a time-point that 
represents peak cytokine levels in sera of MCMV-Δm157 infected mice, that NKG2A-/- 
mice exhibited similar levels of IFNα, but higher levels of IFNγ (Figures 16A and 16B).  
Although these results require further investigation, it could implicate NKG2A in being 
specifically responsible for regulating the NK cell activation, as evidenced by the 
increased IFNγ levels at 36 hrs post infection.  However, NKG2A may be dispensible for 
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overall MCMV infectivity, as judged by the unchanged IFNα concentrations in the 
serum.  These results also require verification after infection with the WT virus.  At this 
time, our working hypothesis is that NKG2A is playing an expected role in the response 
to MCMV.  As an inhibitory NK cell surface receptor, it could be dampening NK cell 
activation and its absence allows for an enhanced anti-viral response.  This would not be 
an evolutionarily conserved function of NKG2A, so we should therefore assess MCMV-
infected tissues for evidence of immunopathology that could be the effect of a less 
regulated NK cell response. 
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Figure 15 
 
 
Figure 15:  NKG2A-/- mice are more resistant to a high infectious dose of MCMV.  
C57BL/6 females were infected with increasing doses of MCMV to determine an LD50 
value (A).  WT and NKG2A-/- mice were infected i.p. with 4ul MCMV diluted in sterile 
PBS and mortality and body weight loss were monitored out to 3 weeks p.i. (B and C).  
NK cell frequencies in the spleen were measured by FACS at days 1, 3, and 6 p.i. (D). 
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Figure 16 
 
 
 
 
 
 
Figure 16:  NKG2A-/- NK cells produce more IFNγ  at early time-points after 
infection with MCMV-Δm157.  WT and NKG2A-/- mice were infected i.p. with 1x104 
PFU MCMV-Δm157 and cytokines were assessed at the indicated times.  IFNα was 
determined by ELISA at 24, 36, and 72 hrs p.i. (A).  IFNγ was determined by cytometric 
bead array at 24, 36, 72, and 192 hrs p.i. (B). 
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NKG2A is not required for efficient licensing of NK cells.  Since NKG2A appears to 
play a role in regulating NK cell activation and numbers post-infection with MCMV, we 
hypothesized that one explanation for this is inefficient licensing of NK cells lacking 
NKG2A-mediated inhibition.  Therefore, we assessed the capability of NK cells from 
both WT and NKG2A-/- to produce IFNγ in a standard licensing assay.  As shown in 
Figure 17A, cells from WT mice that are NKG2x+ do in fact exhibit a higher frequency 
of IFNγ expression following stimulation with plate-bound anti-NK1.1 antibodies (19% 
IFNγ+NKG2+ versus 7% IFNγ+NKG2x-).  However, when directly comparing frequencies 
of IFNγ+ NK cells from WT and NKG2A-/- spleens, we found that there is no difference 
in the frequency of IFNγ+ cells and thus, likely no dominant function for NKG2A in the 
licensing of NK cells (Figure 17B).  Both WT and NKG2A-/- splenic NK cells overall are 
each approximately 12% IFNγ+ in this scenario.  While it is of some interest that NKG2-
expressing cells are more frequently licensed than NKG2- cells, it appears that NKG2 
proteins are not causal in this difference, but maybe just a marker of cells licensed 
through a co-expressed inhibitory receptor. 
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Figure 17 
 
 
 
Figure 17:  NKG2A is dispensable for efficient licensing of NK cells.  Splenocytes 
were stimulated ex vivo with plate-bound anti-NK1.1 and then stained for NK markers 
and intracellular IFNγ.  All plots are gated on CD3-NK1.1+ cell populations.  Frequencies 
of NKG2x+IFNγ+ NK cells (left panel, red box) and NKG2x-IFNγ+ NK cells (left panel, 
green box) are depicted (A).  Frequencies of total IFNγ+ cells in WT and NKG2A-/- 
splenic NK cells (B). 
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Materials and Methods 
 
 
Mice.  KLRG1–/– mice were previously described [Grundemann, 2010 #41].  KLRG1–/– 
and NKG2A–/– animals were bred to generate a double-deficient NKG2A–/–KLRG1–/– 
line.  All mice were bred and housed in specific pathogen-free conditions at accredited 
animal facilities at Washington University in St. Louis and St. Louis University.  To 
generate CD96-/- mice, a targeting vector that would replace the first two exons of the 
CD96 genomic locus was tranfected into 129/OlaHsd embryonic stem cells.  Two clones 
integrated properly, as judged by southern blot screening, and were injected into C57Bl/6 
blastocysts.  Mice heterozygous for the CD96 deletion were successfully bred from the 
chimeric mice.  Heterozygote crosses resulted in the breeding of CD96–/– mice, which 
were born at Mendelian ratios and developed normally out to one year. 
 
HSV-1 intranasal infection.  Mice were anesthetized with 100ul of a ketamine/xylazine 
cocktail and infected with 5x106 PFU HSV-1 Kos.  Virus was diluted with sterile PBS to 
a total volume of 20ul and injected intranasally with a P20 pipettor.  Mice were then 
monitored and weighed for up to 2 weeks post-infection.  Lungs were isolated at the 
indicated time-points and assessed for viral load by standard plaque assays on Vero cell 
monolayers. 
 
Lung CD8 T cell restimulation assay.  Lungs were isolated, rinsed, and minced in 
RPMI.  They were then digested in a cocktail of DNase, hyaluronidase, and Liberase 
Blendzyme 3 for 45 min at 37°C.  Digested lungs were mashed and homogenized over a 
100um mesh filter, RBC-lysed, and refiltered over 100um mesh.  Homogenates were then 
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put in culture with complete media, anti-CD107a antibody, and either irrelevant 
SIINFEKL peptide or the HSV-1 immunodominant peptide SSIEFARL at a 
concentration of 5ug/ml.  Cells were incubated for 1 hour at 37°C and then brefeldin A 
and monensin were added to block golgi transport and secretion.  Cells were incubated 
for a further 5 hrs.  Following incubations, cells were surface stained for T cells markers, 
fixed, permeabilized, and stained for intracellular IFNγ, as described in previous 
methods. 
 
Citrobacter rodentium infection.  C. rodentium culture was obtained from ATCC and 
kept in frozen stocks at -80°C.  Luria broth was inoculated from scrapings of frozen stock 
and grown on a shaker at 37°C until OD600 of the culture ranged between 0.4 and 0.6, 
approximately 5 hrs.  Bacteria number was calculated (OD600 of 1.0 = 8x108 CFU per ml) 
and then WT and CD96-/- mice were infected by orally with 2x109 CFU in a volume of 
25ul, or by gavage in a volume of 200ul.  At 8 days post-infection, the distal 4 cm of 
colons were isolated, mechanically homogenized in sterile PBS, and serially diluted on 
MacConkey agar plates for determination of bacterial load.  Spleens were also isolated, 
weighed, homogenized, and assessed for bacterial load. 
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Results 
	  
NKG2A	  and	  KLRG1	  synergistically	  aid	  the	  host	  response	  to	  ECTV.	  	  NKG2A	  appears	  to	  have	  a	  specific	  function	  in	  maintaining	  the	  CD8	  response	  during	  ECTV	  infection.	  	  We	  therefore	  hypothesized	  that	  other	  inhibitory	  receptors	  may	  also	  contribute	  in	  a	  similar	  manner	  to	  control	  ECTV	  progression.	  	  To	  test	  this	  in	  vivo,	  we	  first	  crossed	  the	  NKG2A-­‐/-­‐	  line	  to	  mice	  engineered	  to	  lack	  KLRG1.	  	  We	  chose	  KLRG1	  because,	  like	  NKG2A,	  it	  is	  a	  lectin-­‐like	  ITIM-­‐containing	  inhibitory	  receptor	  found	  within	  the	  NK	  complex	  of	  mice	  and	  humans.	  	  KLRG1	  is	  also	  dispensable	  for	  development	  and	  several	  infectious	  models,	  which	  could	  be	  due	  to	  either	  redundancy	  with	  other	  inhibitory	  receptors	  or	  an	  undetermined	  and	  highly	  specific	  role	  in	  the	  mouse	  immune	  response.	  	  Therefore,	  we	  crossed	  KLRG1-­‐/-­‐	  mice	  to	  the	  NKG2A-­‐/-­‐	  strain	  to	  generate	  double-­‐knockout	  (DKO)	  mice	  and	  infect	  DKO	  mice	  with	  ECTV.	  	  As	  shown	  in	  Figure	  18A,	  DKO	  mice	  are	  highly	  susceptible	  to	  ECTV	  infection.	  	  Both	  male	  and	  female	  DKO	  mice	  completely	  succumb	  to	  ECTV	  infection,	  whereas	  KLRG1-­‐/-­‐	  mice	  survive	  infection	  comparably	  to	  WT	  mice	  and	  only	  males	  of	  the	  NKG2A-­‐/-­‐	  strain	  succumb.	  	  DKO	  mice	  of	  both	  genders	  also	  lose	  up	  to	  20%	  of	  initial	  body	  weight	  prior	  to	  mortality	  (Figure	  18B).	  	  Furthermore,	  DKO	  mice	  exhibit	  more	  severe	  viraemia	  at	  6	  days	  post-­‐infection	  (Figure	  18C).	  	  Males	  and	  females	  have	  approximately	  10-­‐fold	  more	  virus	  in	  the	  blood	  than	  the	  already	  susceptible	  NKG2A-­‐
/-­‐	  males	  and	  1000-­‐fold	  more	  virus	  than	  KLRG1-­‐/-­‐	  mice.	  	  Together,	  this	  data	  demonstrates	  that	  NKG2A	  and	  KLRG1	  act	  synergistically	  to	  combat	  ECTV	  infection	  and	  further	  establishes	  T	  cell	  and	  NK	  cell	  inhibitory	  receptors	  as	  being	  highly	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important	  to	  controlling	  ECTV.	  	  It	  is	  also	  the	  first	  demonstration	  of	  KLRG1’s	  importance	  to	  the	  control	  of	  a	  viral	  infection	  and	  suggests	  that	  it’s	  function	  in	  this	  and	  perhaps	  other	  infection	  models	  may	  be	  redundant	  with	  other	  inhibitory	  receptors.	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Figure 18 
 
 
 
Figure	  18:	  	  Mice	  lacking	  both	  NKG2A	  and	  KLRG1	  are	  highly	  susceptible	  to	  
ECTV	  infection.	  	  WT,	  NKG2A-­‐/-­‐,	  KLRG1-­‐/-­‐,	  and	  NKG2A-­‐/-­‐KLRG1-­‐/-­‐	  mice	  were	  infected	  in	  the	  footpad	  with	  1000	  PFU	  ECTV-­‐Moscow	  and	  survival	  (A)	  and	  body	  weight	  (B)	  were	  monitored	  over	  time.	  	  ECTV	  genome	  load	  in	  the	  blood	  was	  measured	  by	  qRT-­‐PCR	  at	  6	  days	  p.i.	  and	  compared	  across	  strains	  and	  genders	  (C).	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KLRG1 has a non-redundant role regulating the T cell response to viral infection of 
the lungs. In	  an	  effort	  to	  further	  analyze	  the	  in	  vivo	  function	  of	  KLRG1,	  we	  sought	  to	  assess	  its	  role	  in	  response	  to	  a	  non-­‐systemic	  viral	  infection.	  	  We	  chose	  to	  utilize	  an	  intranasal	  HSV-­‐1	  infection	  model	  because	  it	  had	  previously	  been	  shown	  to	  require	  a	  strong	  effector	  T	  cell	  response	  to	  control	  viral	  replication	  and	  prevent	  viral	  escape	  from	  the	  lung.	  	  We	  infected	  mice	  i.n.	  with	  5x106	  PFU	  of	  the	  Kos	  strain	  of	  HSV-­‐1.	  	  KLRG1-­‐/-­‐	  mice	  exhibit	  reduced	  morbidity	  in	  response	  to	  infection	  (Figure	  19A).	  	  However,	  the	  reduction	  in	  body	  weight	  loss	  does	  not	  correspond	  to	  a	  reduction	  in	  viral	  burden	  at	  any	  time-­‐point	  (Figure	  19B).	  	  In	  the	  broncholeaveolar	  lavage	  fluid	  (BALF),	  there	  is	  a	  reduction	  in	  the	  levels	  of	  inflammatory	  cytokines	  (Figure	  19C).	  	  Therefore,	  we	  hypothesized	  that	  KLRG1-­‐deficiency	  allows	  for	  a	  subtle	  resistance	  to	  lung	  infection	  by	  HSV,	  in	  that	  it	  reduces	  the	  need	  for	  inflammation	  to	  control	  viral	  replication	  during	  the	  peak	  of	  infection.	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Figure 19 
 
 
 
Figure	  19:	  	  KLRG1-­/-­	  mice	  exhibit	  reduced	  morbidity	  and	  inflammation	  in	  
response	  to	  intranasal	  infection	  with	  HSV-­1.	  	  WT	  and	  KLRG1-­‐/-­‐	  mice	  were	  infected	  i.n.	  with	  5x106	  PFU	  HSV-­‐1	  Kos.	  	  Body	  weights	  were	  monitored	  over	  14	  days	  (A)	  and	  viral	  load	  in	  the	  lungs	  was	  assessed	  by	  plaque	  assay	  at	  days	  1,	  3,	  5,	  and	  7	  post-­‐infection	  (B).	  	  Inflammatory	  cytokines	  in	  lavage	  fluid	  were	  measured	  by	  bead	  arrays	  at	  5	  days	  post-­‐infection	  (C).	  	  Black	  bars	  correspond	  to	  WT	  samples	  and	  white	  bars	  to	  KLRG1-­‐/-­‐	  samples.	  	  All	  results	  are	  pooled	  from	  at	  least	  3	  independent	  experiments.	  	  Data	  were	  analyzed	  by	  multiple	  t	  tests. 
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KLRG1-/- CD8 T cells are more numerous and active during HSV-1 lung infection.  Since	  the	  reduced	  morbidity	  in	  KLRG1-­‐/-­‐	  mice	  is	  most	  obvious	  5-­‐7	  days	  post	  infection	  with	  HSV-­‐1,	  we	  sought	  to	  analyze	  the	  effector	  CD8	  response	  in	  WT	  and	  KLRG1-­‐/-­‐	  mice	  at	  those	  time-­‐points.	  	  To	  do	  this,	  we	  isolated	  CD8	  T	  cells	  directly	  from	  the	  lungs	  of	  activated	  mice	  and	  assessed	  their	  numbers	  and	  activation	  state.	  	  As	  shown	  in	  Figure	  20,	  KLRG1-­‐/-­‐	  CD8	  T	  cells	  display	  a	  greater	  ability	  at	  relatively	  early	  time-­‐points	  (5-­‐6	  days	  post-­‐infection)	  to	  produce	  IFNγ	  (Figure	  20A).	  	  Following	  ex	  vivo	  restimulation	  with	  the	  class	  I	  immunodominant	  peptide	  SSIEFARL,	  derived	  from	  the	  HSV-­‐1	  glycoprotein	  B,	  there	  are	  a	  greater	  number	  of	  IFNγ-­‐producing	  KLRG1-­‐/-­‐	  CD8	  T	  cells	  (Figure	  20B	  and	  20C)	  and	  those	  cells	  are	  producing	  more	  IFNγ	  than	  their	  WT	  counterparts	  (Figure	  20D	  and	  20E).	  	  	  KLRG1-­‐/-­‐	  CD8	  T	  cells	  also	  degranulate	  in	  greater	  numbers	  in	  response	  to	  restimulation	  as	  compared	  to	  WT	  cells	  (Figure	  20F).	  	  We	  currently	  hypothesize	  that	  this	  enhanced	  KLRG1-­‐/-­‐	  specific	  CD8	  response	  allows	  for	  less	  inflammation	  and	  morbidity	  during	  the	  anti-­‐HSV	  response,	  while	  fully	  maintaining	  resistance	  to	  HSV-­‐1	  replication	  and	  spread. 
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Figure 20 
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Figure	  20:	  	  CD8+	  T	  cells	  from	  KLRG1-­/-­	  lungs	  show	  an	  early	  specific	  response	  
following	  intranasal	  HSV-­1	  infection.	  	  Lungs	  were	  isolated	  at	  5	  days	  post-­‐infection	  and	  homogenates	  were	  stimulated	  with	  irrelevant	  (Ova257-­‐264,	  SIINFEKL)	  or	  relevant	  (HSV-­‐gB2498-­‐505,	  SSIEFARL)	  peptides	  for	  6	  hours.	  	  CD8+	  T	  cells	  were	  then	  assessed	  for	  intracellular	  IFNg	  (A).	  	  Frequency	  and	  total	  numbers	  of	  IFNg-­‐producing	  CD8+	  T	  cells	  cells	  were	  quantified	  (B	  and	  C),	  as	  was	  the	  MFI	  of	  IFNg	  within	  IFNg+	  cells	  (D).	  	  Secreted	  IFNg	  was	  assessed	  by	  bead	  array	  from	  supernatants	  after	  18hrs	  in	  culture	  (E).	  	  Total	  numbers	  of	  CD8+	  T	  cells	  expressing	  CD107a	  after	  restimulation	  with	  irrelevant	  or	  relevant	  peptides	  were	  determined	  6	  days	  post-­‐infection	  (F).	  	  In	  panels	  A-­‐D	  and	  F,	  CD8+	  T	  cell	  populations	  were	  determined	  as	  CD45+CD3+CD8+	  lymphocytes.	  	  All	  results	  are	  representative	  (A)	  or	  pooled	  (B	  thru	  F)	  from	  at	  least	  2	  independent	  experiments.	  	  Data	  were	  analyzed	  by	  multiple	  t	  tests.	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CD96-/- mice are mildly resistant to gut infection by Citrobacter rodentium.  Previous 
reports had shown that the CD96 ligand, PVR, was expressed in human mucosal tissue.  
Therefore, we sought to assess whether CD96 may have a role in controlling mucosal 
infection.  We chose to utilize C. rodentium, as it is well established as a model infection 
of the gut epithelia.  To begin, WT and CD96-/- mice were infected with 2x109 C. 
rodentium bacteria or mock PBS control.  At 8 days post-infection, the distal 4 cm of the 
colon was harvested and mechanically homogenized, and serially diluted on MacConkey 
agar plates to determine bacterial load.  We found that CD96-/- colons had an 
approximately one log drop in bacterial load (Fig. 21A).  We also noted that CD96-/- 
spleens did not enlarge after infection, as compared to WT spleens (Fig. 21B).   We have 
attempted to titer other organs, including spleens, for evidence of a systemic infection in 
WT or CD96-/- mice, but have not found escaped bacteria.  This is consistent with the 
resistance of C57BL/6 mice to C. rodentium.  These changes imply that CD96 may play a 
role, however, in causing systemic inflammation during C. rodentium infection and its 
presence may be slightly detrimental to clearance.  While this specific activity cannot 
explain the conservation of the CD96 gene, it could point to a function of CD96 that may 
be helpful during other microbial or tumor challenges. 
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Figure 21 
 
 
 
 
 
Figure 21:  CD96-/- mice are mildly resistant to gut infection with C. rodentium:  WT 
and CD96-/- mice were orally infected with 2x109 CFU of C. rodentium.  At day 8 p.i., 
distal colons and spleens were isolated.  The distal 4 cm of colon were isolated, weighed, 
mechanically homogenized, and serially diluted on MacConkey agar plates to determine 
bacterial load from both mock-infected and infected mice (A).  Spleens were also 
weighed from both mock-infected and infected mice (B). 
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CHAPTER FIVE:  Discussion 
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The primary aim of this study has been to establish in vivo roles for inhibitory T 
cell and NK cell receptors in the context of viral infection.  To this end, we report the first 
description of mice specifically lacking NKG2A and establish an in vivo role for it during 
viral infection.  Our studies of NKG2A-/- mice infected with ECTV demonstrate that 
NKG2A is required for survival of subcutaneous infection with this orthopoxvirus.  
Furthermore, NKG2A is necessary to generate an optimal CD8 T cell response that can 
control ECTV infection in the spleen and blood (Figure 22).  Surprisingly, our data shows 
that the defective NKG2A-/- CD8 response is due to a cell-intrinsic defect.  This was 
unexpected, as we initially hypothesized that NK cells lacking NKG2A would play a 
major role in the loss of control of ECTV infection.  Recent reports have demonstrated 
that inhibitory receptors present on the surface of NK cells, including Qa-1, keep those 
cells from aberrantly killing activated CD4 and CD8 T cells during viral infection 
(Crouse et al 2014, Waggoner et al 2010, Xu et al 2014).  Also, NK cells constitutively 
express NKG2 proteins and have been shown to be essential for resistance to ECTV 
infection (Parker et al 2007, Fang et al 2011).  NKG2A-mediated inhibition, at least 
within CD8 T cells, may be more related to that of CTLA4 or PD-1, negative co-
stimulatory molecules that have been shown to prevent broad T cell-dependent 
autoimmune pathologies (Waterhouse et al 1995, Nishimura et al 1999).  The function of 
NKG2A is narrower, as NKG2A-/- mice develop normally under homeostatic conditions 
and other viral infections do not trigger the phenotype observed when NKG2A-/- mice are 
exposed to ECTV.  Nonetheless, our initial study of NKG2A demonstrates that its 
inhibition is required for ECTV resistance and that the requirement appears to be focused 
on maintaining the CD8 response by preventing overactivation that, in this context, leads 
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to cell death.  We are currently to further establish this point.  Thus far, we have shown 
excessive apoptosis of specific cells in an ex vivo culture.  We will also attempt to assess 
the transcriptome of both WT and NKG2A-/- ECTV-specific CD8 T cells via microarray.  
By isolating B8R-specific cells and comparing their transcripts, we hope to conclusively 
show that NKG2A-deficiency results in either disruptions in pro-apoptotic pathways or 
enhancements in anti-apoptotic pathways. 
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Figure 22 
 
 
Figure 22:  How NKG2A may control the CD8 response to ECTV.  NKG2A 
intrinsically enhances CD8 T cell numbers specifically in response to ECTV infection.  
Our data suggests that this is due to NKG2A preventing excessive apoptosis of the 
activated cells.  In this model, CD8 T cells are activated by classical peptide-MHC 
interactions.  Alongside that interaction, NKG2A interacts with a peptide-Qa-1 complex, 
which would limit overactivation of specific CD8 T cells.  In the absence of NKG2A, 
overactivation leads to antigen-induced apoptosis of a large portion of the specific T cell 
pool. 
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Our results also demonstrate that NKG2A plays no role in the CD8 responses to 
VSV, LCMV, or vaccinia virus.  We hypothesize that this may partially be due to its 
ligand, Qa-1, being able to present exogenous peptides (Kraft et al 2000).  In this case, a 
poxvirus derived nonamer may bind Qa-1 specifically, allowing the peptide-MHC 
complex to come to the surface interact with NKG2A-CD94 heterodimers.  The crystal 
structure of NKG2A-CD94 showed that CD94 is mostly responsible for interactions with 
Qa-1/HLA-E itself, while the NKG2 component may show specificity for the presented 
peptide (Petrie et al 2008).  However, this is not likely to be the entire explanation for 
why resistance to ECTV so specifically requires NKG2A.  Our results show that vaccinia 
virus does not require NKG2A-mediated resistance, yet it shares high sequence 
homology with ECTV and likely would synthesize similar peptides to bind within the 
Qa-1 binding groove.  The major difference between ECTV and vaccinia infection is that 
ECTV is particularly virulent in many mouse strains, while vaccinia does not cause 
significant disease in the same mice.  Similarly, VSV and LCMV clone 13 broadly differ 
from ECTV in that they are not usually acutely lethal at low doses of infection.  VSV is 
generally a transient infection on the C57BL/6 background, while LCMV clone 13 
manifests itself as a nonlethal chronic infection.  Therefore, NKG2A’s function on 
specific CD8 T cells may require specific peptides presented to Qa-1, as well as an 
acutely virulent course of infection.  In other infection models, it is likely that NKG2A’s 
function within the CD8 response is somewhat redundant and that other inhibitory 
receptor-ligand interaction replace NKG2A in inhibiting aberrant T cell apoptosis.  In 
fact this has been demonstrated during LCMV clone 13 infection, where the absence of 
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2B4 results in a suboptimal T cell response and exacerbated chronic disease (Waggoner 
et al 2010). 
 Another major focus of this work has been to elucidate the in vivo function of 
KLRG1.  Although KLRG1 is well established as a marker of effector CD8 T cells and 
effector memory CD8 T cells, evidence of its function in any T cell response is lacking 
(Sarkar et al 2008, Grundemann 2010).  Our results show that KLRG1 is important for 
resistance to ECTV, but only when NKG2A is also absent.  KLRG1 single-deficient mice 
respond comparably to WT mice to ECTV, whereas NKG2A-/-KLRG1-/- double-knockout 
(DKO) mice are far more susceptible than NKG2A-/- mice.  This indicates that although 
KLRG1’s function in ECTV resistance is redundant, it nonetheless acts as an important 
backup in the absence of another inhibitory immunoreceptor.  In future studies, it will be 
important to examine whether KLRG1 compensates for the absence of NKG2A or other 
lectin-like immunoreceptors during infection or tumor development. 
 Our results also show that KLRG1 plays a role in clearing viral infection of the 
lungs.  It is important to note that our study is the first to utilize KLRG1-deficient mice in 
the context of a localized mucosal infection.  KLRG1, although apparently dispensible 
within the systemic immune system, may be much more important in a mucosal setting.  
The function of KLRG1 is not redundant in the case of HSV-1 intranasal infection, as the 
lung CD8 response is augmented in KLRG1-/- mice, resulting in less morbidity over the 
course of the infection.  It will be important to analyze how KLRG1 interactions inhibit 
the CD8 response to viral infection of the lungs.  To that end, we are attempting to 
identify a resident or infiltrating APC population that expresses E-cadherin and prime the 
CD8 response either in the lung or in lung-draining lymph nodes.  There is already 
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evidence that mucosal DC subsets express E-cadherin (Siddiqui et al 2010).  However, no 
equivalent cell type has been identified in the lung or shown to functionally interact with 
KLRG1. 
This is not the evolutionarily conserved mechanism of KLRG1 function, as its 
absence results in a better anti-viral response, but it signals that KLRG1, like NKG2A, 
may function to dampen the CD8 response during viral infection.  Therefore, KLRG1 
would be slightly detrimental during a transient, local infection when there is little risk of 
sustained overactivation, but could potentially prevent immunopathology in the context 
of a more severe infection.  We hypothesize that other lung viral infections, such as 
influenza or ECTV, may help us to elucidate the beneficial roles of KLRG1 by pushing 
the CD8 response to its limits and thereby necessitating a role for KLRG1-mediated 
inhibition. 
In conclusion, these studies have revealed novel functions of two lectin-like 
inhibitory immunoreceptors.  Both NKG2A and KLRG1 function to fine-tune the anti-
viral CD8 T cell response.  Their abilities to control CD8 T cells allow for optimal 
clearance of ECTV and suggest that they may also function to limit pathology in response 
to other pathogens.  And given their wider expression in leukocytes, NKG2A and 
KLRG1 may have disparate functions in other immune cell types.  It is our hope that the 
work presented here will lead to further studies in the field and facilitate future 
discoveries in the biomedical sciences. 
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